Lyra Therapeutics LYRA
LYRA
$0.15 +0.12 (+400.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lyra Therapeutics (LYRA) Return on Assets [ROA] (2020 - 2025)

Updated

Lyra Therapeutics (LYRA) posted Return on Assets [ROA] of -72.46% for Q4 2025, up 56.32 percentage points from -128.79% a year earlier but down 4.02 percentage points from the prior quarter.

Analysis

Lyra Therapeutics (LYRA) Return on Assets [ROA] (2020 - 2025) Analysis & Trends

For FY2025, Lyra Therapeutics' Return on Assets [ROA] came in at -56.45%, up 32.98 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -10.26 percentage points (FY2020 to FY2025).
  • In prior years, Lyra Therapeutics' Return on Assets [ROA] was -89.43% in FY2024 (-39.80 pp), -49.63% in FY2023 (+17.44 pp), -67.07% in FY2022 (-2.94 pp) and -64.13% in FY2021 (-17.94 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -129.67% in Q1 2025 to a high of -33.43% in Q1 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last three quarters, with an average year-over-year change of -16.27 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2025, with a gain of 56.32 percentage points; the weakest was Q1 2025, with a drop of 81.19 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -68.44% (Q3 2025), -71.33% (Q2 2025) and -129.67% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Lyra Therapeutics 266,232.31 266,232.31 - -72.46%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -72.46%
Sep 30, 2025 -68.44%
Jun 30, 2025 -71.33%
Mar 31, 2025 -129.67%
Dec 31, 2024 -128.79%
Sep 30, 2024 -112.63%
Jun 30, 2024 -85.88%
Mar 31, 2024 -48.48%
Dec 31, 2023 -47.63%
Sep 30, 2023 -50.15%
Jun 30, 2023 -55.44%
Mar 31, 2023 -58.49%
Dec 31, 2022 -48.18%
Sep 30, 2022 -43.82%
Jun 30, 2022 -57.45%
Mar 31, 2022 -93.18%
Dec 31, 2021 -70.97%
Sep 30, 2021 -51.24%
Jun 30, 2021 -43.14%
Mar 31, 2021 -33.43%
API Access

Lyra Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LYRA&period=max&api_key=YOUR_API_KEY